HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$26.25
Day range
$25.41 - $26.30
Year range
$6.58 - $33.77
Market cap
752.21M USD
Avg Volume
146.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 874.00K | 83.61% |
Operating expense | 18.72M | 129.42% |
Net income | -13.75M | -93.93% |
Net profit margin | -1.57K | -5.62% |
Earnings per share | — | — |
EBITDA | -17.83M | -132.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 377.04M | 474.28% |
Total assets | 382.46M | 431.79% |
Total liabilities | 9.78M | 107.27% |
Total equity | 372.69M | — |
Shares outstanding | — | — |
Price to book | 1.04 | — |
Return on assets | -15.88% | — |
Return on capital | -16.44% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -13.75M | -93.93% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2019
Website
Employees
53